# Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease

> **NCT02612350** · — · COMPLETED · sponsor: **Pathway Genomics** · enrollment: 1106 (actual)

## Conditions studied

- Mutation
- Neoplasms

## Interventions

- **GENETIC:** ctDNA Analysis for the Detection of Genetic Mutations

## Key facts

- **NCT ID:** NCT02612350
- **Lead sponsor:** Pathway Genomics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2017-08
- **Final completion:** 2017-08
- **Target enrollment:** 1106 (ACTUAL)
- **Last updated:** 2018-04-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02612350

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02612350, "Utility of Plasma Circulating Tumor DNA (ctDNA) in Asymptomatic Subjects for the Detection of Neoplastic Disease". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02612350. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*